EuroBio 2009 - the Partnering and Tech Transfer Event for the Bioindustry

September 23-25 2009, Lille, France
To address the needs of both academic researchers and companies by uniting all the actors of the biotechnology sector - especially the starts-ups and spin-offs - EuroBiO 2009 asserts its ambition: to support the transfer of knowledge and expertise from academic research to the economic world.

EuroBiO is a meeting point for emerging/innovative companies, key players of the bioindustry, investment and development partners, institutions and services. The event is tailored to the needs of each participant profile in order to initiate and develop successful alliances at pre-scheduled meetings, networking events and lunches, conferences and workshops with a highlighted exhibition area.

EuroBiOpartnering will enable you to target, define and materialize your development opportunities:

  • Identify today's innovative technologies and tomorrow's products
  • Develop new collaborations and facilitate investment opportunities
  • Select the best partner to support your projects and schedule private one-to-one meetings
  • Maximise your own time on site by pre-arranging your meeting agenda online, including conferences and exhibition visits
  • Link your network and expand your business opportunities following the event by adding the "Matchmaking for Life" application

The partnering system offers all the functions needed to promote your corporate assets, identify business prospects & collaborative partners as well as manage your personalized meeting schedule:

  • Edit and publish your company profile, including product pipeline and licensing opportunities
  • Present your needs and partnering aims effectively
  • Search EuroBiO2009 participants for business prospects and strategic partners
  • Bookmark companies, delegates, offers, sessions in your interests
  • Manage your personal event schedule online
EuroBiO proposes conferences like tool cases from which you can find useful answers and means. Over 110 keynote speakers will share their experiences on four relevant tracks for today's and tomorrow's Biotechs.

For further information and registration, please visit:
http://www.eurobio-event.com

Related news articles:

Most Popular Now

European Artificial Intelligence Act Com…

The European Artificial Intelligence Act (AI Act), the world's first comprehensive regulation on artificial intelligence, enters into force. The AI Act is designed to ensure that AI developed and used...

Patient Safety must be Central to the De…

An EPR system brings together different patient information in one place, making it easier to access for healthcare professionals. This information can include patients' own notes, test results, observations by...

ChatGPT Shows Promise in Answering Patie…

The groundbreaking ChatGPT chatbot shows potential as a time-saving tool for responding to patient questions sent to the urologist's office, suggests a study in the September issue of Urology Practice®...

Survey: Most Americans Comfortable with …

Artificial intelligence (AI) is all around us - from smart home devices to entertainment and social media algorithms. But is AI okay in healthcare? A new national survey commissioned by...

AI Spots Cancer and Viral Infections at …

Researchers at the Centre for Genomic Regulation (CRG), the University of the Basque Country (UPV/EHU), Donostia International Physics Center (DIPC) and the Fundación Biofisica Bizkaia (FBB, located in Biofisika Institute)...

Video Gaming Improves Mental Well-Being

A pioneering study titled "Causal effect of video gaming on mental well-being in Japan 2020-2022," published in Nature Human Behaviour, has conducted the most comprehensive investigation to date on the...

New Diabetes Research Links Blood Glucos…

As part of its ongoing exploration of vocal biomarkers and the role they can play in enhancing health outcomes, Klick Labs published a new study in Scientific Reports - confirming...

Machine learning helps identify rheumato…

A machine-learning tool created by Weill Cornell Medicine and Hospital for Special Surgery (HSS) investigators can help distinguish subtypes of rheumatoid arthritis (RA), which may help scientists find ways to...

New AI Software could Make Diagnosing De…

Although Alzheimer's is the most common cause of dementia - a catchall term for cognitive deficits that impact daily living, like the loss of memory or language - it's not...

A New AI Tool for Cancer

Scientists at Harvard Medical School have designed a versatile, ChatGPT-like AI model capable of performing an array of diagnostic tasks across multiple forms of cancers. The new AI system, described Sept...

Vision-Based ChatGPT Shows Deficits Inte…

Researchers evaluating the performance of ChatGPT-4 Vision found that the model performed well on text-based radiology exam questions but struggled to answer image-related questions accurately. The study's results were published...

Bayer Launches New Healthy-Aging Ecosyst…

Combining a scientifically formulated dietary supplement, a leading-edge wellness companion app, and a saliva-based a biological age test by Chronomics, Bayer is taking a big step in the emerging healthy-aging...